Adaptive Biotechnologies to Participate in Upcoming June 2021 Investor Conferences
May 20 2021 - 4:05PM
Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial
stage biotechnology company that aims to translate the genetics of
the adaptive immune system into clinical products to diagnose and
treat disease, today announced it will be participating virtually
in the following investor conferences.
- William Blair 41st Annual Growth
Stock ConferenceFireside Chat on Tuesday, June 1st at 6:40 a.m.
Pacific Time / 9:40 a.m. Eastern Time
- Goldman Sachs 42nd Annual Global
Healthcare ConferenceFireside Chat on Tuesday, June 8th at 12:50
p.m. Pacific Time / 3:50 p.m. Eastern Time
Interested parties may access a live and
archived webcast of the presentation on the “Investors” section of
the company website at: www.adaptivebiotech.com.
About Adaptive
BiotechnologiesAdaptive Biotechnologies is a
commercial-stage biotechnology company focused on harnessing the
inherent biology of the adaptive immune system to transform the
diagnosis and treatment of disease. We believe the adaptive immune
system is nature’s most finely tuned diagnostic and therapeutic for
most diseases, but the inability to decode it has prevented the
medical community from fully leveraging its capabilities. Our
proprietary immune medicine platform reveals and translates the
massive genetics of the adaptive immune system with scale,
precision and speed to develop products in life sciences research,
clinical diagnostics and drug discovery. We have three commercial
products and a robust clinical pipeline to diagnose, monitor and
enable the treatment of diseases such as cancer, autoimmune
conditions and infectious diseases. Our goal is to develop and
commercialize immune-driven clinical products tailored to each
individual patient.
ADAPTIVE INVESTORSKarina Calzadilla, Vice
President, Investor Relations201-396-1687Carrie
Mendivil, Gilmartin Groupinvestors@adaptivebiotech.com
ADAPTIVE MEDIABeth
Keshishian917-912-7195media@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Apr 2023 to Apr 2024